Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 - 2016)
A clinical trial deals with the application of specific clinical or scientific methods or medicine to the human body. Clinical trials are used to identify the effect of particular treatment or medication on patients suffering from a particular disease. The process of a clinical trial starts with identification of the medication or medical device to be tested. Participants for the trial are selected and the results are studied in order to define the effectiveness of the drug or device.
Clinical trials are very crucial as they involve huge capital investment and may affect the subjects involved. Thus proper management of clinical trials has become a priority for the hospitals. Clinical Trial Management System (CTMS) is a software system employed to manage the large amounts of data involved in a clinical trial. It maintains the planning, preparation, performance, and reporting of clinical trials, including participant information, trial and filing deadlines and other important milestones. The global CTMS market was valued at $576.22 million in 2010. The global CTMS market is estimated to grow at a CAGR of 14.53% during the study period (2011-2016).
Improved clinical trial efficiency with optimized process; centralized database; improved site performance by enhanced investigator relationships; higher subject accrual rate & reduced workload for research coordinators; efficiency in budgeting and financial management; improved cost efficiencies; improved clinical research associate productivity; and automated data processing and report generating are some of the key advantages of CTMS that are driving the market.
Clinical Trial Management System (CTMS) is used by the clinical trial organizations such as Pharmaceutical/Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Healthcare providers (Hospitals, Academic Medical Centers (AMCs) which handle clinical trial. The pharmaceutical CTMS market contributed the largest share; i.e. 49% in 2010. Clinical Research Organizations (CRO) and Healthcare providers contributes 46% and 5% respectively in 2010.
Based on the mode of delivery, the CTMS market is divided into three types; i.e. web-based CTMS, on-Premise CTMS, and cloud-based CTMS. Among all these segments, the web-based market is forecasted to witness the highest CAGR of 15.95% from 2011 to 2016 and is estimated to capture 75% share by 2016 from 70% share in 2010. On-premise CTMS and cloud-based (SAAS) CTMS contributes 28% and 2% respectively in 2010.
North America dominated the global CTMS market with around 62% share in 2010. The U.S. captures the largest market share of North America, and shows a remarkable growth opportunity. The second largest market, Europe, while growth in the Asia-Pacific region is also expected to take greater curves in the near future.
Scope of the Report
This Clinical Trial Management System (CTMS) market research report will enable strategic understanding of the following key segments of the market:
Global CTMS market, by end-users:
Pharmaceutical/biopharmaceutical
Clinical Research Organizations (CRO’s)
Healthcare Providers (Academic institutions/universities, hospitals, and research institutions)
Global CTMS market, by types:
Enterprise CTMS
Site CTMS
Global CTMS market, by components:
Hardware
Software
Services
Global CTMS market, by delivery mode:
On-premises (Licensed Enterprise)
Web-based (Web-hosted)
Cloud-based
The geographies covered under the report are –
North America
U.S.
Canada
Europe
Asia
ROW (Rest of the World)
Each section of the report offers market data for the various market segments and geographies. It also provides market trends with respect to drivers, restraints, and opportunities. The report’s “strategy” section sketches the competitive landscape with about four company profiles.
Global Drug Discovery And Development Industry
TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 ASSUMPTIONS MADE FOR THE REPORT
2 SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 CLINICAL TRIAL DEFINITION
3.1.2 CLINICAL TRIAL PROCESS
3.1.3 CLINICAL TRIAL MANAGEMENT SYSTEM DEFINITION
3.2 ECLINICAL PROCESS & ECLINICAL PLATFORM
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Introduction
3.3.1.2 Ensures patient safety
3.3.1.3 Mitigates costs and offers competitive advantage
3.3.1.4 Secured anytime, anywhere access of web-based and cloud-based CTMS offerings
3.3.1.5 CTMS Integration with other Hospital Information Systems (HIS)
3.3.2 RESTRAINTS
3.3.2.1 Lack of awareness of CTMS in the research community
3.3.2.2 High cost of the system restricts the user count
3.3.2.3 Flexibility issues are more with on-premise CTMS model
3.3.3 OPPORTUNITIES
3.3.3.1 Shift of clinical trials and resources from AMCs to CROs in the past decade
3.3.3.2 Increasing clinical trial Outsourcing trend form Asian countries
3.3.4 MARKET SHARE ANALYSIS, BY COMPETITOR
4 BENEFITS OF CTMS (KEY NEEDS AND BENEFITS INFLUENCING PURCHASING DECISIONS)
4.1 IMPROVED CLINICAL TRIAL EFFICIENCY WITH OPTIMIZED PROCESS & CENTRALIZED DATABASE
4.2 IMPROVES SITE PERFORMANCE BY ENHANCED INVESTIGATOR RELATIONSHIPS
4.3 HIGHER SUBJECT ACCRUAL RATE & REDUCED WORKLOAD FOR RESEARCH COORDINATORS
4.4 EFFECTIVELY MANAGE THE BUDGETING & BILLING ACTIVITES ASSOCIATED WITH CLINICAL TRIALS
4.5 IMPROVED COST EFFICIENCIES THROUGH REDUCED DATA ENTRY AT MULTIPLE SITE & MANUAL LABOR COSTS
4.6 IMPROVED CLINICAL RESEARCH ASSOCIATE PRODUCTIVITY
4.7 AUTOMATED DATA PROCESSING & REPORT GENERATING
5 CHALLENGES/LIMITATIONS/UNMET NEEDS
5.1 EVOLUTION OF CTMS SYSTEM IN A TIMELY MANNER TO IMPROVE THE BUSINESS PROCESS
5.2 INTEROPERABILITY & INTEGRATION ISSUES
5.3 EXTENSIBILITY
5.4 SKEPTICISM IN USAGE & APPLICATIONS
5.5 COST & DURATION OF DEPLOYMENT
6 COMPONENTS OF A CTMS (DRIVERS INFLUENCING THE BUYING PATTERN)
6.1 INTRODUCTION
6.2 PROTOCOL DESIGN & STUDY START UP
6.3 PATIENT & INVESTIGATOR RECRUITMENT
6.4 FINANCIAL MANAGEMENT & BILLING SOLUTIONS
6.5 CLINICAL DATA TRACKING & DATA ANALYSIS MODULE (PATIENT DATA MANAGEMENT & SITE MANAGEMENT)
6.6 DOCUMENT MANAGEMENT SYSTEM (REGULATORY DOCUMENT MANAGEMENT & PROGRESS REPORTS)
6.7 CLINICAL SUPPLIES MANAGEMENT
6.8 ADVERSE EVENTS (AE) & SERIOUS ADVERSE EVENTS (SAE) MANAGEMENT
6.9 CENTRAL DOCUMENT REPOSITORY
7 MARKET BY END-USER (TARGET MARKET FOR CTMS)
7.1 INTRODUCTION
7.2 CLINICAL RESEARCH ORGANIZATIONS (CROS) CTMS MARKET
7.3 PHARMACEUTICAL CTMS MARKET
7.4 HEALTHCARE PROVIDERS CTMS MARKET
8 MARKET BY DELIVERY MODE
8.1 INTRODUCTION
8.2 WEB-BASED (HOSTED) CTMS
8.3 LICENSED ENTERPRISE (ON PREMISE) CTMS
8.4 CLOUD-BASED (SAAS) CTMS
9 MARKET BY COMPONENTS
9.1 INTRODUCTION
9.2 SOFTWARE
9.3 HARDWARE
9.4 SERVICES
10 MARKET BY CTMS TYPE
10.1 INTRODUCTION
10.2 ENTERPRISE CTMS
10.3 SITE CTMS
11 CTMS PENETRATION
12 GEOGRAPHICAL ANALYSIS
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.3 EUROPE
12.4 ASIA
12.5 REST OF THE WORLD (ROW)
13 CLINICAL TRIALS
13.1 INTRODUCTION
13.2 MARKET DYNAMICS FOR CLINICAL TRIALS
13.2.1 DRIVERS
13.2.1.1 Globalizing drug development activities
13.2.1.2 Rise in R&D investments expected to boost the clinical trials market
13.2.1.3 High disease prevalence in emerging countries
13.2.2 RESTRAINT
13.2.2.1 Longer approval time for clinical trials – A cause of concern for major pharmaceutical/ biopharmaceutical players
13.2.3 BURNING ISSUES
13.2.3.1 Out skirting boundaries of medical ethics
13.2.4 WINNING IMPERATIVE
13.2.4.1 Leveraging online resources to increase patient recruitment rates in clinical trials
13.3 CLINICAL TRIAL OUTSOURCING & ROLE OF ACADEMIC RESEARCH ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS
13.3.1 TRADITIONAL ROLE OF ACADEMIC RESEARCH CENTERS IN CONDUCTING CLINICAL TRIALS
13.3.2 TRADITIONAL ROLE OF CROS IN CONDUCTING CLINICAL TRIALS
13.3.3 EVOLVING ROLE OF ACADEMIC RESEARCH CENTERS IN CONDUCTING CLINICAL TRIALS
13.3.3.1 Following are considered as the Key reasons for loss of Market share of AMCs in Clinical trials
13.3.3.1.1 Proliferation of global trials
13.3.3.1.2 Clinical trial duration
13.3.3.1.3 Lack of Self financing capability
13.3.3.1.4 Development of In-house CROs of Pharmaceutical companies
13.3.3.1.5 Increasing clinical trial costs
13.3.4 EVOLVING ROLE OF CROS IN CONDUCTING CLINICAL TRIALS
13.3.4.1 Full service model
13.3.4.2 Hourly billing model
13.3.4.3 Full time equivalent model (FTE)
13.3.4.4 Fixed price model
13.4 CLINICAL TRIALS BY PLAYERS
13.4.1 BY INDUSTRY (CRO, NPO, PHARMACEUTICAL INDUSTRY)
13.4.2 BY INDUSTRY + HEALTHCARE PROVIDERS
13.4.3 BY OTHERS (U.S. FEDERAL ADMINISTRATION & NIH, OTHERS)
14 COMPETITIVE LANDSCAPE
14.1 INTRODUCTION
14.2 COMPETITIVE DEVELOPMENTS
14.2.1 MERGERS & ACQUISITIONS
14.2.2 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/ CONTRACTS
14.2.3 NEW PRODUCTS LAUNCH
14.2.4 EXPANSIONS/NEW FACILITY/INVESTMENTS
14.2.5 OTHERS/FDA APPROVALS/GOVERNMENT GRANTS
15 COMPANY PROFILES
15.1 ARIS GLOBAL LLC
15.1.1 OVERVIEW
15.1.2 FINANCIALS
15.1.3 PRODUCTS & SERVICES
15.1.4 STRATEGY
15.1.5 DEVELOPMENTS
15.2 BIOCLINICA INC.
15.2.1 OVERVIEW
15.2.2 FINANCIALS
15.2.3 PRODUCTS & SERVICES
15.2.4 STRATEGY
15.2.5 DEVELOPMENTS
15.3 BIO-OPTRONICS INC.
15.3.1 OVERVIEW
15.3.2 FINANCIALS
15.3.3 PRODUCTS & SERVICES
15.3.4 STRATEGY
15.3.5 DEVELOPMENTS
15.4 BUSINESS SYSTEMS INTEGRATION AG
15.4.1 OVERVIEW
15.4.2 FINANCIALS
15.4.3 PRODUCTS & SERVICES
15.4.4 STRATEGY
15.4.5 DEVELOPMENTS
15.5 DIGIPORT HOLDINGS PRIVATE LTD
15.5.1 OVERVIEW
15.5.2 FINANCIALS
15.5.3 PRODUCTS & SERVICES
15.5.4 STRATEGY
15.5.5 DEVELOPMENTS
15.6 DSG INC.
15.6.1 OVERVIEW
15.6.2 FINANCIALS
15.6.3 PRODUCTS & SERVICES
15.6.4 STRATEGY
15.6.5 DEVELOPMENTS
15.7 ERESEARCH TECHNOLOGY INC. (ERT)
15.7.1 OVERVIEW
15.7.2 FINANCIALS
15.7.3 PRODUCTS & SERVICES
15.7.4 STRATEGY
15.7.5 DEVELOPMENTS
15.8 FORTE RESEARCH SYSTEMS
15.8.1 OVERVIEW
15.8.2 FINANCIALS
15.8.3 PRODUCTS & SERVICES
15.8.4 STRATEGY
15.8.5 DEVELOPMENTS
15.9 GOBALTO
15.9.1 OVERVIEW
15.9.2 FINANCIALS
15.9.3 PRODUCTS & SERVICES
15.9.4 STRATEGY
15.9.5 DEVELOPMENTS
15.10 INNOVOCOMMERCE LLC
15.10.1 OVERVIEW
15.10.2 FINANCIALS
15.10.3 PRODUCTS & SERVICES
15.10.4 STRATEGY
15.10.5 DEVELOPMENTS
15.11 INTEGRATED CLINICAL SOLUTIONS INC.
15.11.1 OVERVIEW
15.11.2 FINANCIALS
15.11.3 PRODUCTS & SERVICES
15.11.4 STRATEGY
15.11.5 DEVELOPMENT
15.12 MEDIDATA SOLUTIONS
15.12.1 OVERVIEW
15.12.2 FINANCIALS
15.12.3 PRODUCTS & SERVICES
15.12.4 STRATEGY
15.12.5 DEVELOPMENTS
15.13 MEDNET SOLUTIONS
15.13.1 OVERVIEW
15.13.2 FINANCIALS
15.13.3 PRODUCTS & SERVICES
15.13.4 STRATEGY
15.13.5 DEVELOPMENTS
15.14 MERGE HEALTHCARE INCORPORATED
15.14.1 OVERVIEW
15.14.2 FINANCIALS
15.14.3 PRODUCTS & SERVICES
15.14.4 STRATEGY
15.14.5 DEVELOPMENTS
15.15 NEXTRIALS INC.
15.15.1 OVERVIEW
15.15.2 FINANCIALS
15.15.3 PRODUCTS & SERVICES
15.15.4 STRATEGY
15.15.5 DEVELOPMENTS
15.16 OMNICOMM SYSTEMS INC.
15.16.1 OVERVIEW
15.16.2 FINANCIALS
15.16.3 PRODUCTS & SERVICES
15.16.4 STRATEGY
15.16.5 DEVELOPMENTS
15.17 ORACLE CORPORATION
15.17.1 OVERVIEW
15.17.2 FINANCIALS
15.17.3 PRODUCTS & SERVICES
15.17.4 STRATEGY
15.17.5 DEVELOPMENTS
15.18 ORIAM
15.18.1 OVERVIEW
15.18.2 FINANCIALS
15.18.3 PRODUCTS & SERVICES
15.18.4 STRATEGY
15.18.5 DEVELOPMENTS
15.19 PAREXEL INTERNATIONAL CORPORATION
15.19.1 OVERVIEW
15.19.2 FINANCIALS
15.19.3 PRODUCTS & SERVICES
15.19.4 STRATEGY
15.19.5 DEVELOPMENTS
15.20 SPARTA SYSTEMS INC.
15.20.1 OVERVIEW
15.20.2 FINANCIALS
15.20.3 PRODUCTS & SERVICES
15.20.4 STRATEGY
15.20.5 DEVELOPMENTS
15.21 STUDYMANAGER INC.
15.21.1 OVERVIEW
15.21.2 FINANCIALS
15.21.3 PRODUCTS & SERVICES
15.21.4 STRATEGY
15.21.5 DEVELOPMENTS
15.22 TRIAL BY FIRE SOLUTIONS
15.22.1 OVERVIEW
15.22.2 FINANCIALS
15.22.3 PRODUCTS & SERVICES
15.22.4 STRATEGY
15.22.5 DEVELOPMENTS
15.23 OTHERS
15.23.1 ECLINFORCE INC.
15.23.1.1 Overview
15.23.1.2 Financials
15.23.1.3 Products & services
15.23.1.4 Strategy
15.23.2 VOLODYNE TECHNOLOGIES
15.23.2.1 Overview
15.23.2.2 Financials
15.23.2.3 Products & services
15.23.2.4 Strategy
15.23.3 DATABEAN LLC
15.23.3.1 Overview
15.23.3.2 Financials
15.23.3.3 Products & services
15.23.3.4 Strategy
15.23.4 CLINTRIAL WORKS
15.23.4.1 Overview
15.23.4.2 Financials
15.23.4.3 Products & services
15.23.4.4 Strategy
LIST OF TABLES
TABLE 1 CTMS MARKET SIZE, BY GEOGRAPHY, 2008 – 2016 (MILLION)
TABLE 2 GLOBAL CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 3 CRO CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 4 NORTH AMERICA: CRO CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 5 PHARMACEUTICAL CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 6 NORTH AMERICA: PHARMACEUTICAL CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 7 PROVIDER CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 8 NORTH AMERICA: PROVIDER CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 9 CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 10 WEB-BASED CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 11 NORTH AMERICA: WEB-BASED CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 12 ON-PREMISE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 13 NORTH AMERICA: ON-PREMISE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 14 CLOUD-BASED CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 15 NORTH AMERICA: CLOUD-BASED CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 16 CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 17 SOFTWARE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 18 NORTH AMERICA: SOFTWARE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 19 HARDWARE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 20 NORTH AMERICA: HARDWARE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 21 SERVICES CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 22 NORTH AMERICA: SERVICES CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 23 CTMS MARKET REVENUE, BY TYPES, 2008 – 2016 ($MILLION)
TABLE 24 ENTERPRISE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 25 NORTH AMERICA: ENTERPRISE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($ MILLION)
TABLE 26 SITE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
TABLE 27 NORTH AMERICA: SITE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 28 CTMS PENETRATION, BY GEOGRAPHY, 2010
TABLE 29 NORTH AMERICA: CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)
TABLE 30 NORTH AMERICA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 31 NORTH AMERICA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 32 NORTH AMERICA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 33 NORTH AMERICA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)
TABLE 34 U.S: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 35 U.S: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 36 U.S.: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 37 U.S: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)
TABLE 38 CANADA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 39 CANADA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 40 CANADA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 41 CANADA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)
TABLE 42 EUROPE: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 43 EUROPE: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 44 EUROPE: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 45 EUROPE: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)
TABLE 46 ASIA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 47 ASIA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 48 ASIA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 49 ASIA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)
TABLE 50 ROW: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)
TABLE 51 ROW: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)
TABLE 52 ROW: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)
TABLE 53 ROW: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)
TABLE 54 MARKET SHARE OF HEALTHCARE PROVIDERS IN GLOBAL CLINICAL TRIALS, 1998 – 2007
TABLE 55 DRIFT OF NORTH AMERICAN SHARE IN GLOBAL CLINICAL TRIAL, 1990 – 2007
TABLE 56 BIOCLINICA INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 57 BIOCLINICA INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 58 ERESEARCH TECHNOLOGY INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 59 ERESEARCH TECHNOLOGY INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 60 ERESEARCH TECHNOLOGY INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 61 MEDIDATA SOLUTIONS: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 62 MEDIDATA SOLUTIONS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 63 MEDIDATA SOLUTIONS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 64 MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 65 MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 66 MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 67 OMNICOMM SYSTEMS INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 68 ORACLE CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 69 ORACLE CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 70 ORACLE CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 71 PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 72 PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 73 PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
LIST OF FIGURES
FIGURE 1 PROCESS OF CLINICAL TRIALS
FIGURE 2 DRIVERS & RESTRAINTS FOR CTMS MARKET
FIGURE 3 MARKET SHARE ANALYSIS, BY COMPETITORS, (BASED ON SOFTWARE LICENSE REVENUE SHARE), 2010
FIGURE 4 MODULES OF CTMS
FIGURE 5 CTMS MARKET, BY END-USERS, 2010
FIGURE 6 CTMS MARKET, BY DELIVERY MODE, 2010 VS. 2016
FIGURE 7 CTMS MARKET SHARE, BY COMPONENTS, 2010
FIGURE 8 CTMS PENETRATION, BY GEOGRAPHY, 2010 (%)
FIGURE 9 CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)
FIGURE 10 MARKET SHARE OF HEALTHCARE PROVIDERS IN GLOBAL CLINICAL TRIALS, 1998 VS 2007
FIGURE 11 DRIFT OF NORTH AMERICAN SHARE IN GLOBAL CLINICAL TRIAL, 1990 – 2007
FIGURE 12 GRANT FUNDED VS. SELF FINANCING TRIALS
FIGURE 13 INDUSTRY VS AMC WITH/WITHOUT GRANT VS NIH/U.S. FED ALONE
FIGURE 14 INDUSTRY VS. INDUSTRY PLUS AMC
FIGURE 15 INDUSTRY VS. AMC VS. U.S. FED PLUS NIH
FIGURE 16 INDUSTRY VS. AMC VS. US FED VS. NIH
FIGURE 17 KEY GROWTH STRATEGIES, 2008 – 2011
